Navigation Links
Humanwell PuraCap Pharmaceutical LLC Announces Successful FDA Inspection

SOUTH PLAINFIELD, N.J., Nov. 12, 2015 /PRNewswire/ -- PuraCap Pharmaceutical LLC is pleased to announce that the US Food and Drug Administration (FDA) has completed a successful inspection of its affiliated soft gelatin capsule manufacturing facility, Humanwell PuraCap Pharmaceutical (Wuhan) Co, Ltd, located in Wuhan, Hubei Province China. The inspection confirmed that the site is compliant with Current Good Manufacturing Practices, and NO Form 483 observations were issued. This FDA inspection took place on May 18 through May 22, 2015.

Photo -
Logo -

Dahai Guo, Chief Executive Officer commented, " This successful inspection is the culmination of years of planning, development and training to achieve our goal of building a world class pharmaceutical manufacturing facility in China. It reflects the tireless work of the Humanwell PuraCap team of manufacturing and quality professionals."

Xiaofeng Meng, VP of Global Regulatory and Quality added, "We have always measured our cGMP and Quality performance and have consistently achieved the highest potential scores on outside audits from global customers as well as 3rd-party authority, such as UL-STR, Intertek etc.  An FDA inspection without observations is a testimony to our commitment to world-class quality and continuous improvement."

About PuraCap Pharmaceutical LLC

PuraCap Pharmaceutical LLC is an emerging, fully integrated pharmaceutical company with expertise in product development, manufacturing, and bringing affordable, world-class quality products to their customers.  The PuraCap corporate structure supports a two-pronged approach for global growth with dedicated companies in the areas of prescription brands (PuraCap Pharmaceutical) as well as prescription generics and OTC drugs.   PuraCap Pharmaceutical continues to innovate using our soft gel expertise and developing other oral solid options. Go to for more information.  

Forward-Looking Statement

All of the statements contained in this news release, other than statements of fact that are independently verifiable at the date hereof, are forward-looking statements. Such statements, based as they are on the current expectations of management, inherently involve numerous risks and uncertainties, known and unknown. Some examples of known risks are: the impact of general economic conditions, general conditions in the pharmaceutical industry, changes in the regulatory environment in the jurisdictions in which PuraCap Pharmaceutical LLC does business, fluctuations in costs, and changes to the competitive environment due to consolidation or otherwise. Consequently, actual future results may differ materially from the anticipated results expressed in the forward-looking statements.

Media Contact:

Elise Klein
Vice President and General Manager
Branded Rx Products
908-941-5456 ext. 640

SOURCE PuraCap Pharmaceutical LLC
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. PuraCap Pharmaceutical Seeks Damages From InvaGen for Contract Violation
2. Cumberland Pharmaceuticals To Present At The UBS Global Healthcare Conference In New York
3. Aoxing Pharmaceutical Company, Inc. Announces Financial Results For Third Quarter Of 2013 Fiscal Year
4. Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeants Board of Directors
5. DelMar Pharmaceuticals, Inc. Provides Corporate Update for the Quarter Ended March 31, 2013
6. Access Pharmaceuticals Reports First Quarter Results
7. The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals
8. Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference
9. AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
10. Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment
11. Aveo Pharmaceuticals, Inc. Sued by Investor
Post Your Comments:
(Date:1/12/2020)... (PRWEB) , ... January 11, 2020 , ... Lerner and ... by supporting the Crohn's and Colitis Foundation’s inaugural Courage Ball. This special evening takes ... Las Vegas Blvd.). Guests are invited to arrive early at 6:00 p.m. for cocktails ...
(Date:1/12/2020)... ... January 12, 2020 , ... FutuRx, Israel’s ... - JJDC, and Takeda Ventures, Inc, operating under a tender from the Israeli ... in collaboration with Ramot at Tel-Aviv University and Glasgow University. , Epeius ...
(Date:1/10/2020)... ... January 10, 2020 , ... Reach Higher at the Common ... high school counselors and award the first annual Excellence in College Counseling Award. ... Extra Yard for Teachers Summit celebration on Saturday, January 11th. In addition to ...
Breaking Medicine Technology:
(Date:1/24/2020)... ... 2020 , ... SweetLeaf Stevia Sweetener, the world’s most trusted ... Jorge Cruise to educate consumers on losing weight through better diets with low ... fasting, that is fat burning and boosting your energy, and for reducing added ...
(Date:1/23/2020)... ... 23, 2020 , ... A January 7 article from Good Housekeeping ... The article quotes the president of the American Society of Plastic Surgeons who says ... caused by a person’s facial structure including an undefined jawline, a loss of elasticity ...
(Date:1/23/2020)... , ... January 23, 2020 , ... ... in the state’s life-science industry, presents a panel discussion on gene editing that ... the ChristianaCare John H. Ammon Medical Education Center, the event will provide an ...
(Date:1/23/2020)... (PRWEB) , ... January 23, 2020 , ... ... University Hospitals have pledged to take action to improve diagnostic quality and safety ... 60 of the most prominent organizations in healthcare and patient advocacy. , “Diagnostic ...
(Date:1/23/2020)... ... January 23, 2020 , ... Driving ... organizations that operate vehicle fleets in North America and around the globe, has ... published monthly with content accessible on the company’s website. , Developed for fleet ...
Breaking Medicine News(10 mins):